— Know what they know.
Not Investment Advice

CSTL NASDAQ

Castle Biosciences, Inc.
1W: +8.8% 1M: -18.2% 3M: -29.7% YTD: -46.7% 1Y: +24.5% 3Y: -9.4% 5Y: -62.8%
$20.15
-0.39 (-1.90%)
 
Weekly Expected Move ±12.7%
$14 $17 $19 $22 $24
NASDAQ · Healthcare · Medical - Diagnostics & Research · Alpha Radar Strong Sell · Power 28 · $611.1M mcap · 27M float · 1.53% daily turnover · Short 54% of daily vol

📊 Key Metrics

TTM
$340M
Revenue
-2.1% YoY
$-13M
Net Income
-153.1% YoY
$5M
Free Cash Flow
-89.2% YoY
72.2%
Gross Margin
-22.0%
Op. Margin
-17.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-2.8%
ROA-2.3%
ROIC-12.6%

Valuation

P/E-47.3
P/B1.3
EV/EBITDA-98.4

Leverage

Debt/Equity0.08
Current Ratio5.26
Interest Cov.-106.4x

Quality Scores

Piotroski F3/9
Altman Z4.62
Beneish M-3.10

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms